Researchers at U of T Engineering have developed a new way of growing realistic human tissues outside the body. Their “person-on-a-chip” technology, called AngioChip, is a powerful platform for discovering and testing new drugs, and could eventually be used to repair or replace damaged organs.
Professor Milica Radisic (IBBME, ChemE), graduate student Boyang Zhang and their collaborators are among those research groups around the world racing to find ways to grow human tissues in the lab, under conditions that mimic a real person’s body. They have developed unique methods for manufacturing small, intricate scaffolds for individual cells to grow on. These artificial environments produce cells and tissues that resemble the real thing more closely than those grown lying flat in a petri dish.
he team’s recent creations have included BiowireTM — an innovative method of growing heart cells around a silk suture — as well as a scaffold for heart cells that snaps together like sheets of Velcro™. But AngioChip takes tissue engineering to a whole new level. “It’s a fully three-dimensional structure complete with internal blood vessels,” says Radisic. “It behaves just like vasculature, and around it there is a lattice for other cells to attach and grow.” The work — which is published todayin the journal Nature Materials — was produced collaboratively with researchers from across U of T, including Professor Michael Sefton (ChemE, IBBME), Professor Aaron Wheeler (Chemistry, IBBME) and their research teams, as well as researchers from Toronto General Hospital and University Health Network.
Zhang built the scaffold out of POMaC, a polymer that is both biodegradable and biocompatible. The scaffold is built out of a series of thin layers, stamped with a pattern of channels that are each about 50 to 100 micrometres wide. The layers, which resemble the computer microchips, are then stacked into a 3D structure of synthetic blood vessels. As each layer is added, UV light is used to cross-link the polymer and bond it to the layer below.
When the structure is finished, it is bathed in a liquid containing living cells. The cells quickly attach to the inside and outside of the channels and begin growing just as they would in the human body.
“Previously, people could only do this using devices that squish the cells between sheets of silicone and glass,” says Radisic. “You needed several pumps and vacuum lines to run just one chip. Our system runs in a normal cell culture dish, and there are no pumps; we use pressure heads to perfuse media through the vasculature. The wells are open, so you can easily access the tissue.”
Using the platform, the team has built model versions of both heart and liver tissues that function like the real thing. “Our liver actually produced urea and metabolized drugs,” says Radisic. They can connect the blood vessels of the two artificial organs, thereby modelling not just the organs themselves, but the interactions between them. They’ve even injected white blood cells into the vessels and watched as they squeezed through gaps in the vessel wall to reach the tissue on the other side, just as they do in the human body.
AngioChip has great potential in the field of pharmaceutical testing. Current drug-testing methods, such as animal testing and controlled clinical trials, are costly and fraught with ethical concerns. Testing on lab-grown human tissues would provide a realistic model at a fraction of the cost, but this area of research is still in its infancy. “In the last few years, it has become possible to order cultures of human cells for testing, but they’re grown on a plate, a two-dimensional environment,” says Radisic. “They don’t capture all the functional hallmarks of a real heart muscle, for example.”
A more realistic platform like AngioChip could enable drug companies to detect dangerous side effects and interactions between organ compartments long before their products reach the market, saving countless lives. It could also be used to understand and validate the effectiveness of current drugs and even to screen libraries of chemical compounds to discover new drugs. Through TARA Biosystems Inc., a spin-off company co-founded by Radisic, the team is already working on commercializing the technology.
In future, Radisic envisions her lab-grown tissues being implanted into the body to repair organs damaged by disease. Because the cells used to seed the platform can come from anyone, the new tissues could be genetically identical to the intended host, reducing the risk of organ rejection. Even in its current form, the team has shown that the AngioChip can be implanted into a living animal, its artificial blood vessels connected to a real circulatory system. The polymer scaffolding itself simply biodegrades after several months.
Learn more: ‘Person-on-a-chip’ — U of T engineers create lab-grown heart and liver tissue for drug testing and more
The Latest on: Tissue engineering
[google_news title=”” keyword=”tissue engineering” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Tissue engineering
- Using MRI, engineers have found a way to detect light deep in the brainon May 10, 2024 at 6:39 am
That dilation can then be observed with magnetic resonance imaging (MRI), allowing researchers to pinpoint the source of light. "A well-known problem that we face in neuroscience, as well as other ...
- New technique bioprints live cells inside the body using ultrasonic waveson May 8, 2024 at 10:36 pm
Revolutionary acousto-printing method can be used to circumvent invasive surgery, and has a wide array of potential applications.
- Fresh hope for chronic woundson May 8, 2024 at 7:44 am
New approaches in drug delivery for brain cancer At UD, Pochan continues to explore new uses for the UD-developed biomaterials, from immunotherapy to tissue engineering. In one project, his research ...
- Tissue Engineering of Vascular Prosthetic Graftson May 7, 2024 at 10:43 pm
The book Tissue Engineering of Vascular Prosthetic Grafts, edited by Peter Zilla and Howard Greisler, explores the basic biology, clinical background and pathology of synthetic vascular graft ...
- Green Biomaterials for Tissue Engineering and Nanomedicine Applications: Recent Advances and Future Trendson May 7, 2024 at 7:22 am
The global ecological burden that includes the progressive fossil resources depletion and the simultaneous global population growth and waste production intensification, requires adequate efforts for ...
- Tissue Engineering Market Competition: Assessing Key Challenges and Opportunitieson May 5, 2024 at 4:28 pm
The global tissue engineering market size was US$ 12.1 billion in 2021. The global tissue engineering market is forecast to grow to US$ 39.4 billion by 2030 by registering a compound annual growth ...
- Novel fabrication method creates aligned nanofiber hydrogels for tissue regenerationon May 3, 2024 at 10:12 pm
A team of chemists and bioengineers at Rice University and the University of Houston have achieved a significant milestone in their work to create a biomaterial that can be used to grow biological ...
- New experimental evidence unlocks a puzzle in vascular tissue engineeringon April 25, 2024 at 9:25 am
Angiogenesis is a process of forming hierarchical vascular networks in living tissues. Its complexity makes the controlled generation of blood vessels in laboratory conditions a highly challenging ...
- Tissue Engineering News and Researchon April 23, 2024 at 5:00 pm
The field of bone tissue engineering (BTE) was a promising avenue for addressing bone injuries and defects by constructing artificial scaffolds with bionic functionalities. The promising results ...
- Will Heart Valve Tissue Engineering Change the World?on April 14, 2024 at 5:00 pm
Nat Clin Pract Cardiovasc Med. 2005;2(2):60-61. Several strategies for heart valve tissue engineering are evolving. They include the use of decellularized allogenic or xenogenic valve matrices ...
via Bing News